Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Platform for Molecular Testing, Treatment and Outcome of Patients With Multiple Myeloma (Myeloma Registry Platform; MYRIAM)

NCT03308474 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT03308474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03308474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Platform for Molecular Testing, Treatment and Outcome of Patients With Multiple Myeloma (Myeloma Registry Platform; MYRIAM)
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Recruiting
Start date
September 25, 2017
Completion date
December 31, 2028
Enrollment
2,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma